Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease

References

• Westney GE, Judson MA. Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med. 2006;27(3):453–462, vi. ​ ​
   PubMed Web of Science ®Google Scholar
• Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol. 1974;99(4):250–257.
   PubMed Web of Science ®Google Scholar
• Chappell AG, Cheung WY, Hutchings HA. Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17(2):167–173.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Nagai S, Balter M, et al. Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28(1):56–64.
   PubMed Web of Science ®Google Scholar
• Moller DR. Pulmonary fibrosis of sarcoidosis. New approaches, old ideas. Am J Respir Cell Mol Biol. 2003;29(3 Suppl):S37–41.
   PubMed Web of Science ®Google Scholar
• Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29(2):119–127.
   PubMed Web of Science ®Google Scholar
• Shlobin OA, Nathan SD. Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation. Eur Respir J. 2012;39(6):1520–1533.
   PubMed Web of Science ®Google Scholar
• Zhang C, Chan KM, Schmidt LA, et al. Histopathology of Explanted Lungs From Patients With a Diagnosis of Pulmonary Sarcoidosis. Chest. 2016;149(2):499–507.
   PubMed Web of Science ®Google Scholar
• Shigemitsu H, Oblad JM, Sharma OP, et al. Chronic interstitial pneumonitis in end-stage sarcoidosis. Eur Respir J. 2010;35(3):695–697.
   PubMed Web of Science ®Google Scholar
• Xu L, Kligerman S, Burke A. End-stage sarcoid lung disease is distinct from usual interstitial pneumonia. Am J Surg Pathol. 2013;37(4):593–600.
   PubMed Web of Science ®Google Scholar
• Mostard RL, Verschakelen JA, van Kroonenburgh MJ, et al. Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis. Respir Med. 2013;107(3):439–447.
   PubMed Web of Science ®Google Scholar
• Valeyre D, Bernaudin JF, Jeny F, et al. Pulmonary Sarcoidosis. Clin Chest Med. 2015;36(4):631–641.
   PubMed Web of Science ®Google Scholar
• Patterson KC, Hogarth K, Husain AN, et al. The clinical and immunologic features of pulmonary fibrosis in sarcoidosis. Transl Res. 2012;160(5):321–331.
   PubMed Web of Science ®Google Scholar
• Kruit A, Grutters JC, Ruven HJ, et al. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest. 2006;129(6):1584–1591.
   PubMed Web of Science ®Google Scholar
• Prasse A, Pechkovsky DV, Toews GB, et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med. 2006;173(7):781–792.
   PubMed Web of Science ®Google Scholar
• Koth LL, Solberg OD, Peng JC, et al. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am J Respir Crit Care Med. 2011;184(10):1153–1163.
   PubMed Web of Science ®Google Scholar
• Huang CT, Heurich AE, Sutton AL, et al. Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis. 1981;62(4):231–238.
   PubMedGoogle Scholar
• Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J. 1961;2(5261):1165–1172.
   PubMed Web of Science ®Google Scholar
• Remy-Jardin M, Giraud F, Remy J, et al. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology. 1994;191(3):675–680.
   PubMed Web of Science ®Google Scholar
• Abehsera M, Valeyre D, Grenier P, et al. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR. 2000;174(6):1751–1757.
   PubMed Web of Science ®Google Scholar
• Brauner MW, Grenier P, Mompoint D, et al. Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology. 1989;172(2):467–471.
   PubMed Web of Science ®Google Scholar
• Patel DC, Budev M, Culver D. Advanced (“end-stage”) pulmonary sarcoidosis. In: Judson MA, ed. Pulmonary sarcoidosis: a guide for the practicing clinician. New York (NY): Springer; 2014. p. 79–110.
   Google Scholar
• Judson MA, Strange C. Bullous sarcoidosis: a report of three cases. Chest. 1998;114(5):1474–1478.
   PubMed Web of Science ®Google Scholar
• Miller WT Jr., Chatzkel J, Hewitt MG. Expiratory air trapping on thoracic computed tomography. A diagnostic subclassification. Ann Am Thorac Soc. 2014;11(6):874–881.
   PubMedGoogle Scholar
• Jeong YJ, Lee KS, Chung MP, et al. Chronic hypersensitivity pneumonitis and pulmonary sarcoidosis: differentiation from usual interstitial pneumonia using high-resolution computed tomography. Semin Ultrasound CT MR. 2014;35(1):47–58.
   PubMed Web of Science ®Google Scholar
• Nardi A, Brillet PY, Letoumelin P, et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J. 2011;38(6):1368–1373.
   PubMed Web of Science ®Google Scholar
• Teirstein AT, Morgenthau AS. “End-stage” pulmonary fibrosis in sarcoidosis. Mt Sinai J Med. 2009;76(1):30–36.
   PubMedGoogle Scholar
• Patterson KC, Strek ME. Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc. 2013;10(4):362–370.
   PubMedGoogle Scholar
• Polychronopoulos VS, Prakash UB. Airway involvement in sarcoidosis. Chest. 2009;136(5):1371–1380.
   PubMed Web of Science ®Google Scholar
• Hansell DM, Milne DG, Wilsher ML, et al. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology. 1998;209(3):697–704.
   PubMed Web of Science ®Google Scholar
• Zar HJ, Cole RP. Bullous emphysema occurring in pulmonary sarcoidosis. Respiration. 1995;62(5):290–293.
   PubMed Web of Science ®Google Scholar
• Judson MA, Stevens DA. The treatment of pulmonary aspergilloma. Curr Opin Investig Drugs. 2001;2(10):1375–1377.
   PubMedGoogle Scholar
• Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J. 2013;41(3):621–626.
   PubMed Web of Science ®Google Scholar
• Research Committee of the British Thoracic and Tuberculosis Association. Aspergilloma and residual tuberculous cavities–the results of a resurvey. Tubercle. 1970;51(3):227–245. ​
   PubMedGoogle Scholar
• Kravitz JN, Berry MW, Schabel SI, et al. A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma. Chest. 2013;143(5):1414–1421.
   PubMed Web of Science ®Google Scholar
• Pena TA, Soubani AO, Samavati L. Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature. Lung. 2011;189(2):167–172.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Lower EE. Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients. Respir Med. 2013;107(12):2009–2013.
   PubMed Web of Science ®Google Scholar
• Hennebicque AS, Nunes H, Brillet PY, et al. CT findings in severe thoracic sarcoidosis. Eur Radiol. 2005;15(1):23–30.
   PubMed Web of Science ®Google Scholar
• Lewis MM, Mortelliti MP, Yeager H Jr., et al. Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(2):154–159.
   PubMed Web of Science ®Google Scholar
• Judson MA, Baughman RP. Worsening of pulmonary sarcoidosis. Curr Opin Pulm Med. 2014;20(5):508–516.
   PubMed Web of Science ®Google Scholar
• Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157(1):9–21.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Engel PJ, Taylor L, et al. Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest. 2010;138(5):1078–1085.
   PubMed Web of Science ®Google Scholar
• Rosen Y, Moon S, Huang CT, et al. Granulomatous pulmonary angiitis in sarcoidosis. Arch Pathol Lab Med. 1977;101(4):170–174.
   PubMed Web of Science ®Google Scholar
• Takemura T, Matsui Y, Oritsu M, et al. Pulmonary vascular involvement in sarcoidosis: granulomatous angiitis and microangiopathy in transbronchial lung biopsies. Virchows Archiv. 1991;418(4):361–368.
   Web of Science ®Google Scholar
• Westcott JL, DeGraff AC Jr. Sarcoidosis, hilar adenopathy, and pulmonary artery narrowing. Radiology. 1973;108(3):585–586.
   PubMed Web of Science ®Google Scholar
• Swigris JJ, Olson AL, Huie TJ, et al. Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007. Chest. 2011;140(5):1261–1266.
   PubMed Web of Science ®Google Scholar
• Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax. 2006;61(1):68–74.
   PubMed Web of Science ®Google Scholar
• Handa T, Nagai S, Miki S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest. 2006;129(5):1246–1252.
   PubMed Web of Science ®Google Scholar
• Shorr AF, Helman DL, Davies DB, et al. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J. 2005;25(5):783–788.
   PubMed Web of Science ®Google Scholar
• Milman N, Burton CM, Iversen M, et al. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?. J Heart Lung Transplant. 2008;27(3):329–334.
   PubMed Web of Science ®Google Scholar
• Shorr AF, Davies DB, Nathan SD. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest. 2003;124(3):922–928.
   PubMed Web of Science ®Google Scholar
• Arcasoy SM, Christie JD, Pochettino A, et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest. 2001;120(3):873–880.
   PubMed Web of Science ®Google Scholar
• Pietinalho A, Ohmichi M, Lofroos AB, et al. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17(2):158–166.
   PubMed Web of Science ®Google Scholar
• Akira M, Kozuka T, Inoue Y, et al. Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest. 2005;127(1):185–191.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Judson MA, Teirstein A, et al. Presenting characteristics as predictors of duration of treatment in sarcoidosis. QJM. 2006;99(5):307–315.
   PubMed Web of Science ®Google Scholar
• Gottlieb JE, Israel HL, Steiner RM, et al. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest. 1997;111(3):623–631.
   PubMed Web of Science ®Google Scholar
• Mana J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration. 1994;61(4):219–225.
   PubMed Web of Science ®Google Scholar
• Heron M, van Moorsel CH, Grutters JC, et al. Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosis. Tissue Antigens. 2011;77(2):112–117.
   PubMedGoogle Scholar
• Sato H, Williams HR, Spagnolo P, et al. CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis. Eur Respir J. 2010;35(2):324–330.
   PubMed Web of Science ®Google Scholar
• Su R, Li MM, Bhakta NR, et al. Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes. Eur Respir J. 2014;44(4):985–993.
   PubMed Web of Science ®Google Scholar
• Sweiss NJ, Salloum R, Gandhi S, et al. Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations. PLos One. 2010;5(2):e9088.
   PubMed Web of Science ®Google Scholar
• Panselinas E, Judson MA. Acute pulmonary exacerbations of sarcoidosis. Chest. 2012;142(4):827–836.
   PubMed Web of Science ®Google Scholar
• Manouvrier-Hanu S, Puech B, Piette F, et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature. Am J Med Genet. 1998;76(3):217–221.
   PubMed Web of Science ®Google Scholar
• Zhong J, Roth M. Lung remodeling mechanisms in chronic lung diseases. Curr Opin Allergy Clin Immunol. 2014;14(1):69–76.
   PubMed Web of Science ®Google Scholar
• Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364(16):1503–1512.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Noth I, Garcia JG, et al. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N Engl J Med. 2011;364(16):1576–1577.
   PubMed Web of Science ®Google Scholar
• Stock CJ, Sato H, Fonseca C, et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax. 2013;68(5):436–441.
   PubMed Web of Science ®Google Scholar